# Pymaceuticals scc Analysis

### Project Summary:
Compared the performance of Pymaceuticals' drug of interest, Capomulin, versus the other treatment regimens. 
Used matplotlib to generate all of the tables and figures needed for a technical report of the study.

### Conclusions:
* Capomulin is a viable drug regimen to reduce tumor growth. Capomulin had the most number of mice complete the study, with the exception of Remicane, all other regimens observed a number of mice deaths across the duration of the study. 
* There is a strong correlation between mouse weight and tumor volume, indicating that mouse weight may be contributing to the effectiveness of any drug regimen.
